Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 6, 1976 - Issue 3
6
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Stereospecific Inversion of l-α-Methylfluorene-2-acetic Acid to its d-Enantiomer in the Dog

, , &
Pages 159-169 | Received 15 Aug 1975, Published online: 30 Sep 2009
 

Abstract

1. After administration of dl-α-methylfluorene-2-acetic acid to dogs, the optical rotation of the drug in blood increased with time. Of the total drug in blood, the d-enantiomer increased from 61 to 80% between 3 and 24 h after administration; by 384 h it was 100%.

2. Both l- and d-enantiomers had plasma half-lives and excretion characteristics similar to those of the dl-racemic mixture, indicating that the increase in the proportion of the d-enantiomer was not due to more rapid excretion of the l-enantiomer.

3. Studies of optical rotation and circular dichroism demonstrated that the l-enantiomer was converted to the d-enantiomer in the blood of the dog, but the d-enantiomer remained unchanged. After administration of the l-enantiomer, the d-enantiomer increased from 26 to 71% of the total drug in blood between 0.3 and 2 days after administration; 14 days after dosing, almost all of the drug was present as the d-enantiomer.

4. Isomerization of l-α-methylfluorene-2-acetic acid to its d-enantiomer also occurs in rat. monkev and man.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.